**Meet the editor**

Hala Gali-Muhtasib obtained her PhD in Biology in 1990 after which she was awarded a postdoctoral research fellowship in the Anticancer Drug Laboratory in Manhattan, KS. In 1993 she accepted a research associate position at the Department of Physiology and Biophyscis, Case Western Reserve University School of Medicine, Cleveland, OH. She then joined AUB in 1994 as an Assis-

tant Professor and was promoted to full Professor in 2004. H. Gali-Muhtasib has published more than 65 manuscripts in peer-reviewed international journals and 11 book chapters. Her research interests are in the field of cancer chemoprevention and chemotherapy, particularly in what relates to the study of plant-derived compounds, hypoxic cytotoxic agents, anti-angiogenic drugs and radiation modifier compounds in an attempt to study the interplay between tumor hypoxia, radiosensitization and angiogenesis. Her efforts have been directed towards understanding the cellular and molecular mechanisms of action of various anticancer agents using cellular biology techniques as well as an emerging array of molecular technologies. She has been honored with three research achievement awards; the Suad al-Sabbah prize in 2003, the Abdul Hameed Shoman prize for Young Arab Researchers in 2004 and the ISESCO prize in Biology in 2008.

Contents

**Preface IX** 

Öner Özdemir

Chapter 1 **May Mast Cells Have Any Effect** 

Chapter 2 **The Application of Membrane** 

Chapter 3 **The Airways: A Promising Route** 

Chapter 4 **Cell Division Gene from Bacteria** 

Chapter 6 **Binary Radiotherapy of Melanoma** 

Chapter 7 **Clinical Development Paradigms** 

Nguyen Tu H.K.

**Part 1 New Modalities of Cancer Treatment 1** 

**Vesicles for Cancer Therapy 21**  Khan Salma, Jutzy Jessica M.S.,

Guilleminault L., Hervé-Grépinet V., Lemarié E. and Heuzé-Vourc'h N.

**in Minicell Production for Therapy 83** 

Chapter 5 **Vascular-Targeted Photodynamic Therapy (VTP) 99**  Ezatul Ezleen Kamarulzaman, Hamanou Benachour, Muriel Barberi-Heyob, Céline Frochot, Habibah A Wahab,

> Victor Kulakov, Elena Grigirjeva, Elena Koldaeva, Alisa Arnopolskaya and Alexey Lipengolts

Gisela González, Tania Crombet and Agustín Lage

**for Cancer Vaccines: The Case of CIMAvax EGF® 145** 

François Guillemin and Régis Vanderesse

**– Russian Research Results 123** 

**in New Modalities of Cancer Treatment? 3** 

Aspe Jonathan R., Valenzuela Malyn May A., Park Joon S., Turay David and Wall Nathan R.

**for the Pulmonary Delivery of Anticancer Agents 53** 
